Zurich Cantonal Bank’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.4K | Buy |
3,289
+899
| +38% | +$7.46K | ﹤0.01% | 2459 |
|
|
2026
Q1 | $20K | Buy |
2,390
+1,020
| +74% | +$10.7K | ﹤0.01% | 2456 |
|
|
2025
Q4 | $19.7K | Sell |
1,370
-314
| -19% | -$3.91K | ﹤0.01% | 2467 |
|
|
2025
Q3 | $16.3K | Buy |
1,684
+287
| +21% | +$2.54K | ﹤0.01% | 2484 |
|
|
2025
Q2 | $11.5K | Sell |
1,397
-156
| -10% | -$1.31K | ﹤0.01% | 2513 |
|
|
2025
Q1 | $11.1K | Sell |
1,553
-15,108
| -91% | -$112K | ﹤0.01% | 2587 |
|
|
2024
Q4 | $129K | Buy |
16,661
+4,548
| +38% | +$42.7K | ﹤0.01% | 2341 |
|
|
2024
Q3 | $127K | Hold |
12,113
| – | – | ﹤0.01% | 2334 |
|
|
2024
Q2 | $142K | Buy |
12,113
+272
| +2% | +$4.23K | ﹤0.01% | 2215 |
|
|
2024
Q1 | $249K | Buy |
11,841
+1,301
| +12% | +$23.1K | ﹤0.01% | 1929 |
|
|
2023
Q4 | $189K | Hold |
10,540
| – | – | ﹤0.01% | 2111 |
|
|
2023
Q3 | $173K | Buy |
10,540
+3,379
| +47% | +$61.2K | ﹤0.01% | 2061 |
|
|
2023
Q2 | $143K | Buy |
7,161
+1,952
| +37% | +$37.6K | ﹤0.01% | 2134 |
|
|
2023
Q1 | $98.5K | Hold |
5,209
| – | – | ﹤0.01% | 2285 |
|
|
2022
Q4 | $118K | Buy |
5,209
+1,096
| +27% | +$24.8K | ﹤0.01% | 2171 |
|
|
2022
Q3 | $109K | Hold |
4,113
| – | – | ﹤0.01% | 2147 |
|
|
2022
Q2 | $102K | Hold |
4,113
| – | – | ﹤0.01% | 2233 |
|
|
2022
Q1 | $137K | Sell |
4,113
-1,210
| -23% | -$33.6K | ﹤0.01% | 2129 |
|
|
2021
Q4 | $174K | Sell |
5,323
-76
| -1% | -$2.59K | ﹤0.01% | 2165 |
|
|
2021
Q3 | $226K | Sell |
5,399
-6
| -0.1% | -$216 | ﹤0.01% | 1841 |
|
|
2021
Q2 | $210K | Buy |
5,405
+68
| +1% | +$2.43K | ﹤0.01% | 1766 |
|
|
2021
Q1 | $182K | Buy |
5,337
+1,224
| +30% | +$52.2K | ﹤0.01% | 1837 |
|
|
2020
Q4 | $187K | Buy |
4,113
+1,112
| +37% | +$38.9K | ﹤0.01% | 1890 |
|
|
2020
Q3 | $83K | Hold |
3,001
| – | – | ﹤0.01% | 2065 |
|
|
2020
Q2 | $111K | Hold |
3,001
| – | – | ﹤0.01% | 1892 |
|
|
2020
Q1 | $97K | Buy |
3,001
+1,128
| +60% | +$47K | ﹤0.01% | 1622 |
|
|
2019
Q4 | $77K | Hold |
1,873
| – | – | ﹤0.01% | 1888 |
|
|
2019
Q3 | $67K | Hold |
1,873
| – | – | ﹤0.01% | 1831 |
|
|
2019
Q2 | $96K | Hold |
1,873
| – | – | ﹤0.01% | 1642 |
|
|
2019
Q1 | $107K | Sell |
1,873
-364
| -16% | -$18K | ﹤0.01% | 1543 |
|
|
2018
Q4 | $94K | Hold |
2,237
| – | – | ﹤0.01% | 1636 |
|
|
2018
Q3 | $169K | Hold |
2,237
| – | – | ﹤0.01% | 1406 |
|
|
2018
Q2 | $161K | Hold |
2,237
| – | – | ﹤0.01% | 1373 |
|
|
2018
Q1 | $67K | Buy |
2,237
+1,214
| +119% | +$35.3K | ﹤0.01% | 1855 |
|
|
2017
Q4 | $34K | Buy |
+1,023
| New | +$30.8K | ﹤0.01% | 2243 |
|
Other funds holding RGNX
RG
Zurich Cantonal Bank's RGNX Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Regenxbio (RGNX) stake by 38% in Q2 2026, buying an estimated $7.46K and bringing the position to 3,289 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2459.
Zurich Cantonal Bank first reported a position in RGNX in Q4 2017 and has held it in 35 quarters since. The position peaked at $249K in Q1 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Zurich Cantonal Bank held 3,289 shares of Regenxbio worth $39.4K as of Q2 2026.
- Zurich Cantonal Bank bought 899 Regenxbio shares in Q2 2026, an estimated $7.46K.
- Regenxbio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2459 holding.
- Zurich Cantonal Bank first reported a position in Regenxbio in Q4 2017 and has held it in 35 quarters since.
- Zurich Cantonal Bank's Regenxbio position peaked at $249K in Q1 2024.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.